SI1560827T1 - Antiinfekcijska sredstva - Google Patents

Antiinfekcijska sredstva

Info

Publication number
SI1560827T1
SI1560827T1 SI200331953T SI200331953T SI1560827T1 SI 1560827 T1 SI1560827 T1 SI 1560827T1 SI 200331953 T SI200331953 T SI 200331953T SI 200331953 T SI200331953 T SI 200331953T SI 1560827 T1 SI1560827 T1 SI 1560827T1
Authority
SI
Slovenia
Prior art keywords
compound
hcv
inhibiting
processes
polymerase
Prior art date
Application number
SI200331953T
Other languages
English (en)
Inventor
John K Pratt
David A Betebenner
Pamela L Donner
Brian E Green
Dale J Kempf
Keith F Mcdaniel
Clarence J Maring
Vincent S Stoll
Rong Zhang
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/285,714 external-priority patent/US20040097492A1/en
Priority claimed from US10/625,121 external-priority patent/US20040162285A1/en
Priority claimed from US10/679,881 external-priority patent/US20050075331A1/en
Application filed by Abbott Lab filed Critical Abbott Lab
Priority claimed from EP03768559A external-priority patent/EP1560827B1/en
Publication of SI1560827T1 publication Critical patent/SI1560827T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
SI200331953T 2002-11-01 2003-10-31 Antiinfekcijska sredstva SI1560827T1 (sl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US10/285,714 US20040097492A1 (en) 2002-11-01 2002-11-01 Anti-infective agents
US10/410,853 US20040087577A1 (en) 2002-11-01 2003-04-10 Anti-infective agents
US10/625,121 US20040162285A1 (en) 2002-11-01 2003-07-23 Anti-infective agents
US10/679,881 US20050075331A1 (en) 2003-10-06 2003-10-06 Anti-infective agents
EP03768559A EP1560827B1 (en) 2002-11-01 2003-10-31 Anti-infective agents
PCT/US2003/034707 WO2004041818A1 (en) 2002-11-01 2003-10-31 Anti-infective agents

Publications (1)

Publication Number Publication Date
SI1560827T1 true SI1560827T1 (sl) 2011-04-29

Family

ID=43426110

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200331953T SI1560827T1 (sl) 2002-11-01 2003-10-31 Antiinfekcijska sredstva

Country Status (6)

Country Link
JP (2) JP4738172B2 (sl)
AT (1) ATE493408T1 (sl)
DE (1) DE60335564D1 (sl)
DK (1) DK1560827T3 (sl)
PT (1) PT1560827E (sl)
SI (1) SI1560827T1 (sl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA100120C2 (en) 2007-04-03 2012-11-26 Анадис Фармасьютикалз, Инк. 5,6-dihydro-1h-pyridin-2-one compounds
GB0800855D0 (en) * 2008-01-17 2008-02-27 Syngenta Ltd Herbicidal compounds
AU2009241514A1 (en) * 2008-04-15 2009-11-05 Intermune, Inc. Novel inhibitors of hepatitis C virus replication
JP2012506885A (ja) * 2008-10-29 2012-03-22 ビーエーエスエフ ソシエタス・ヨーロピア 除草作用を有する置換ピリジン
KR20110122874A (ko) * 2009-03-06 2011-11-11 에프. 호프만-라 로슈 아게 헤테로사이클릭 항바이러스 화합물
US8895608B2 (en) * 2010-04-23 2014-11-25 Kineta, Inc. Sulfonamide anti-viral compounds
EA023336B1 (ru) * 2011-06-07 2016-05-31 Анадис Фармасьютикалз, Инк. Соединения [1,2,4]тиадиазин 1,1-диоксида для снижения мочевой кислоты в сыворотке

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1292310A1 (en) * 2000-05-10 2003-03-19 SmithKline Beecham Corporation Novel anti-infectives
AR036081A1 (es) * 2001-06-07 2004-08-11 Smithkline Beecham Corp Compuesto de 1,2-dihidroquinolina, su uso para preparar una composicion farmaceutica, metodos para prepararlo y compuestos del acido 2-aminobenzoico n-alquilado de utilidad como intermediarios en dichos metodos
WO2003059356A2 (en) * 2001-10-30 2003-07-24 Smithkline Beecham Corporation Novel anti-infectives

Also Published As

Publication number Publication date
JP5250649B2 (ja) 2013-07-31
DE60335564D1 (de) 2011-02-10
JP4738172B2 (ja) 2011-08-03
DK1560827T3 (da) 2011-04-18
ATE493408T1 (de) 2011-01-15
JP2006509042A (ja) 2006-03-16
PT1560827E (pt) 2011-03-17
JP2011144183A (ja) 2011-07-28

Similar Documents

Publication Publication Date Title
EP2361913A8 (en) Anti-infective agents
WO2007076034A3 (en) Anti-viral compounds
WO2007081517A8 (en) Anti-viral compounds
AP1782A (en) Use of compounds ?-D or ?-L nucleoside for treating hepatitis C virus.
BR0305259A (pt) Inibidores de hcv ns5b polimerase
BR0309581A (pt) Derivados de nucleosìdeo para tratamento de infecção por vìrus de hepatite c
WO2004009020A3 (en) Pyrrolopyrimidine thionucleoside analogs as antivirals
EE05709B1 (et) Nukleosiidhend, seda sisaldav farmatseutiline kompositsioon ning hendi kasutamine viiruse RNA-s?ltuva RNA polmeraasi inhibiitorina toimiva ravimi valmistamiseks
EA200900156A1 (ru) Пиридазиновое соединение (варианты), способ его получения (варианты), способ лечения или профилактики инфекционного вирусного гепатита с с его помощью, композиция и лекарственное средство на его основе
TW200518746A (en) Novel inhibitors of hepatitis C virus NS3/NS4A serine protease
WO2005054430A3 (en) Hepatitis c virus inhibitors
DK1521754T3 (da) Virale inhibitorer
WO2008057871A3 (en) Inhibitors of hepatitis c virus
WO2004043339A3 (en) Substituted cycloalkyl p1' hepatitis c virus inhibitors
BR0110023A (pt) Derivados de nucleosìdeo 3'-ou-2' substituìdos para tratamento de infecções por vìrus da hepatite
PL1719773T3 (pl) Skondensowane związki heterotetracykliczne i ich zastosowanie jako inhibitora polimerazy HCV
HK1122292A1 (en) Anti-viral compounds
BR0115447A (pt) Inibidores de tripeptìdeo de hepatite c
BRPI0515596A (pt) composição farmacêutica usada para o tratamento e/ou prevenção de hcv, e, métodos de inibir rna polimerase ns5b de hepatite c de tratar ou prevenir infecção por hepatite c em um mamìfero
ATE542826T1 (de) Inhibitoren des hepatitis-c-virus
ID27787A (id) Senyawa, komposisi dan metode untuk pengobatan atau pencegahan infeksi yang disebabkan oleh virus dan penyakit-penyakit yang berkaitan
TW200505944A (en) Crystalline phases of a potent HCV inhibitor
WO2001055131A3 (en) Prodigiosin-derivatives as neoplastic and anti-viral agents
SI1560827T1 (sl) Antiinfekcijska sredstva
WO2006085141A3 (en) Compositions and methods for treating or preventing hepadnaviridae infection